Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
27.23
+0.17 (0.63%)
Mar 9, 2026, 3:35 PM EDT - Market open
Genmab Employees
Genmab had 2,973 employees as of December 31, 2025. The number of employees increased by 339 or 12.87% compared to the previous year.
Employees
2,973
Change (1Y)
339
Growth (1Y)
12.87%
Revenue / Employee
$1,251,261
Profits / Employee
$323,915
Market Cap
16.46B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Moderna | 4,700 |
| BioMarin Pharmaceutical | 3,221 |
| Jazz Pharmaceuticals | 2,890 |
| Incyte | 2,844 |
| Ionis Pharmaceuticals | 1,402 |
| Ascendis Pharma | 1,189 |
| Exelixis | 1,077 |
| Revolution Medicines | 883 |
GMAB News
- 5 hours ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 5 days ago - Genmab A/S at TD Cowen Healthcare Conference Transcript - GuruFocus
- 6 days ago - Correction to Company Announcement No. 13 of March 2, 2026 - GlobeNewsWire
- 6 days ago - Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons - GlobeNewsWire
- 7 days ago - Wells Fargo Initiates Coverage on Genmab (GMAB) with Overweight Rating | GMAB Stock News - GuruFocus
- 7 days ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 9 days ago - Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons - GlobeNewsWire
- 9 days ago - Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab - GlobeNewsWire